| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Insider buying and selling activity across 114 companies in the Pharmaceuticals industry. Part of the Health Care sector.
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Sep 11, 2025 | VTRS Viatris Inc | Le Goff Corinne | Chief Commercial Officer | Sell | 7,032 | $10.25 | $72,044.95 | -16.6% | +14.1% | - | |
| Sep 11, 2025 | BSPK Bespoke Extracts, Inc. | Feinsod Michael | CEO | Buy | 3,500 | $0.22 | $785.00 | - | - | - | |
| Sep 11, 2025 | UTHR United Therapeutics Corp | Rothblatt Martine A58 | Chairperson &CEO | Sell | 8,000 | $397.97 | $3,183,776.80 | -77.0% | +19.8% | - | |
| Sep 11, 2025 | PLNH Planet 13 Holdings Inc. | Wren Chris | VP Of Operations | Sell | 66,758 | $0.27 | $18,097.65 | -0.7% | - | - | |
| Sep 11, 2025 | PAHC Phibro Animal Health Corp | Bendheim Jack49 | President And CEO | Sell | 21,120 | $40.59 | $857,313.25 | -14.4% | -3.2% | - | |
| Sep 10, 2025 | UTHR United Therapeutics Corp | Thompson Tommy G51 | Director | Sell | 4,560 | $403.36 | $1,839,321.60 | -35.0% | +20.1% | - | |
| Sep 9, 2025 | UTHR United Therapeutics Corp | Rothblatt Martine A58 | Chairperson &CEO | Sell | 8,000 | $398.55 | $3,188,374.29 | -79.2% | +18.7% | - | |
| Sep 9, 2025 | UTHR United Therapeutics Corp | Malcolm Jan | Director | Sell | 700 | $400.29 | $280,203.00 | -57.4% | +18.7% | - | |
| Sep 9, 2025 | UTHR United Therapeutics Corp | Benkowitz Michael47 | President And COO | Sell | 16,375 | $395.82 | $6,481,612.42 | -51.9% | +18.7% | - | |
| Sep 8, 2025 | PRGO Perrigo Co Plc | Lennox Abigail | EVP And CSO | Buy | 1,255 | $22.41 | $28,124.55 | New | -41.4% | - | |
| Sep 8, 2025 | SUPN Supernus Pharmaceuticals, Inc. | Khattar Jack A.64 | President, CEO | Sell | 6,322 | $46.29 | $292,645.38 | -0.6% | +2.9% | - | |
| Sep 8, 2025 | BSPK Bespoke Extracts, Inc. | Feinsod Michael | CEO | Buy | 2,500 | $0.19 | $475.00 | - | - | - | |
| Sep 8, 2025 | BHC Bausch Health Companies Inc. | Carson Seana60 | EVP, General Counsel | Sell | 13,370 | $7.31 | $97,734.70 | -2.6% | -7.0% | - | |
| Sep 5, 2025 | PRGO Perrigo Co Plc | Atkinson Charles | EVP, General Counsel &Sec. | Buy | 1,000 | $23.20 | $23,200.00 | New | -40.4% | - | |
| Sep 5, 2025 | TEVA Teva Pharmaceutical Industries Ltd | McAvoy David R. | EVP, Chief Legal Officer | Buy | 1,113 | $18.86 | $20,988.06 | +9.3% | +49.9% | - | |
| Sep 5, 2025 | SUPN Supernus Pharmaceuticals, Inc. | Khattar Jack A.64 | President, CEO | Sell | 55,578 | $46.01 | $2,557,143.78 | -4.8% | -2.0% | - | |
| Sep 5, 2025 | AQST Aquestive Therapeutics, Inc. | Boyd Peter E.81 | See Remarks | Sell | 15,000 | $5.30 | $79,500.00 | -4.9% | +18.8% | - | |
| Sep 5, 2025 | BSPK Bespoke Extracts, Inc. | Feinsod Michael | CEO | Buy | 2,500 | $0.20 | $500.00 | - | - | - | |
| Sep 5, 2025 | KNSA Kiniksa Pharmaceuticals International, Plc | Tessari Eben | Chief Operating Officer | Sell | 98,660 | $35.54 | $3,506,277.66 | -52.6% | +14.8% | - | |
| Sep 4, 2025 | UTHR United Therapeutics Corp | Mahon Paul A47 | EVP &General Counsel | Sell | 11,000 | $385.21 | $4,237,281.09 | -2.0% | +26.4% | - | |
| Sep 4, 2025 | AQST Aquestive Therapeutics, Inc. | Jung Cassie | Chief Operating Officer | Sell | 62,180 | $5.00 | $310,900.00 | -18.0% | +21.5% | - | |
| Sep 4, 2025 | JNJ Johnson & Johnson | Taubert Jennifer L60 | EVP, Wwc. Innovative Medicine | Sell | 56,471 | $177.81 | $10,040,882.63 | -24.1% | +14.9% | - | |
| Sep 4, 2025 | PCRX Pacira Biosciences, Inc. | Ceesay Abraham | Director | Sell | 2,354 | $27.19 | $64,005.26 | -20.7% | -9.5% | - | |
| Sep 4, 2025 | KNSA Kiniksa Pharmaceuticals International, Plc | Moat Ross | Chief Corp. &Comm. Officer | Sell | 3,523 | $35.31 | $124,397.13 | -27.2% | +14.3% | - | |
| Sep 3, 2025 | LQDA Liquidia Corp | Singh Raman | Director | Sell | 7,500 | $29.42 | $220,650.00 | -19.4% | +5.4% | - |
The blue line has two modes, toggled with the Relative and Absolute buttons:
Relative (default) shows cumulative industry performance with both the overall market and parent sector movements removed. When the line rises above 100, the industry is outperforming its sector; below 100 means underperforming. This is calculated using factor returns via weighted least squares (WLS) regression, isolating pure industry-specific behavior.
Absolute shows the total cumulative return of the industry including market and sector movement. This reflects what an investor actually experienced — an industry can show strong absolute gains even while underperforming its sector in relative terms.
Both views start at an index of 100. Other return drivers such as momentum, value, or size are deliberately retained in both modes, since these are part of what makes an industry behave the way it does and may reflect the conditions insiders are responding to.